Viewing Study NCT06641856


Ignite Creation Date: 2025-12-24 @ 11:29 PM
Ignite Modification Date: 2026-01-02 @ 8:17 AM
Study NCT ID: NCT06641856
Status: RECRUITING
Last Update Posted: 2024-10-29
First Post: 2024-10-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Respiratory Virome Diversity and Baseline Immunity in Healthy Individuals in Shanghai
Sponsor: Ruijin Hospital
Organization:

Study Overview

Official Title: Respiratory Virome Diversity and Baseline Immunity in Healthy Individuals in Shanghai
Status: RECRUITING
Status Verified Date: 2024-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study investigates the diversity of the respiratory virome in healthy individuals in Shanghai and its interaction with the host's baseline immune response. The respiratory virome plays a critical role in various diseases, but research on the respiratory virome in healthy individuals in China is limited. This prospective study will analyze the upper and lower respiratory virome and examine the effects of demographic factors such as age, gender, and geographic background. Additionally, a respiratory virome database will be established, and multi-omics approaches will be used to study immune response mechanisms in relation to virome diversity.
Detailed Description: The study aims to provide comprehensive baseline data on the respiratory virome in healthy individuals in Shanghai. The primary goal is to investigate virome diversity in the upper and lower respiratory tracts and assess how demographic factors influence virome composition. Furthermore, the study will identify previously unknown viral sequences and explore their potential role in the immune system's interaction with the virome. Multi-omics approaches, including transcriptomics and proteomics, will be utilized to evaluate immune-related biomarkers and gene expression related to respiratory virome diversity.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: False
Is an FDA AA801 Violation?: